Clinical characteristics, mode of presentation and pathological features of resectable carcinoma of the colon have been studied in 224 cases presenting between January 1971 and December 1975. Minimum length of follow-up is five years and is complete. Forty-three per cent of patients survived five years or more, only 23 per cent of tumours being early in histological terms. The conventional high risk groups contributed little to the total and their active surveillance will not significantly improve the overall statistics.
TNM Classification of Malignant Tumours. 3rd Edition. Ed: HarmerMH, International Union Against Cancer, Geneva1978.
2.
HardcastleJD, FarrandsPA, BalfourTW. Controlled trial of faecal occult blood testing in the detection of colorectal cancer. Lancet1983; 2: 1–4.
3.
LeicesterR, AntoniaLightfoot, JudithMillar, Colin-JonesDG, HuntRH. Accuracy and value of the Hemoccult test in symptomatic patients. Br Med. J1983; 286: 673–674.
4.
Lennard-JonesJE, MorsonBC, JeanK Ritchie, WilliamsCB. Cancer surveillance in ulcerative colitis. Experience over 15 years. Lancet1983; 2: 149–152.
5.
JeanK Ritchie, HawleyPR, Lennard-JonesJE. Prognosis of carcinoma in ulcerative colitis. Gut1981; 22: 752–755.
6.
GydeSN, PriorP, ThompsonH, WatterhouseJAH, AllanRN. Survival of patients with colorectal cancer complicating ulcerative colitis. Gut1984; 25: 228–231.
